Pharmteco

Learn how to navigate the regulatory landscape utilizing current method development technologies for impurity control in late-phase API manufacturing.

https://www.chromatographyonline.com/lcgc_w/control-strategies

This webinar will cover the method development strategies for control of nitrosamines in drug substances and drug products. There will be a focus on platform method development across liquid chromatography-tandem mass spectrometry (LC-MS-MS), high-resolution LC-MS, and gas chromatography-mass spectrometry (GC-MS), and application of these methods to challenging drug substances and drug products. The webinar will include a review of method development and validation case studies for nitrosamines of concerns, as well as strategies for drug-derived nitrosamines to ensure you bring your drugs into compliance ahead of the August 2025 deadline.

Discuss the regulatory landscape for nitrosamines and nitrosamine drug substance-related impurities (NDSRIs)

Learn to select the right analytical technologies for nitrosamines assessment

Understand different method development and validation strategies

Chemistry manufacturing control (CMC) and regulatory leaders

Analytical scientists working in method development

Scientists with an interest in the determination of drug substance and product nitrosamines control

Scientists with an interest in high-performance liquid chromatography (HPLC) or GC separations and MS

Procurement and sourcing managers in the pharmaceutical industry

Shankar Sankaran is director of analytical at SK pharmteco, where he oversees method development, validation, release testing, stability studies, and reference standard management for both CDMO operations and contract analytical services. With over 16 years at the organization, Shankar previously worked as a laboratory chemist, and has taken on increasing responsibilities in quality control and method development to support API programs from early to late phases and into commercial stages.

Webcasts

Webinar Date/Time: Thu, Nov 7, 2024 9:00 AM PST (12:00 PM EST)


Pharmteco

Articles